Clinical trials
Retinal Vein Occlusion trials in China with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| He Eye Hospital | 2 |
| Renmin Hospital of Wuhan University | 2 |
| Chengdu Kanghong Biotech Co., Ltd. | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| Shanghai BDgene Co., Ltd. | 1 |
| Sun Yat-sen University | 1 |
| Wenbin Wei | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Retinal Vein Occlusion | 9 |
| Choroid Diseases | 1 |
| Macular Degeneration | 1 |
| Macular Edema | 1 |
| Neovascularization, Pathologic | 1 |
| Retinal Diseases | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.